Cover Image

Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection

Show other versions (1)

<h4>Purpose</h4> Vancomycin-resistant enterococci infection is a worrying worldwide clinical problem. To evaluate the accuracy of GeneXpert vanA/vanB in the diagnosis of VRE, we conducted a systematic review in the study. <h4>Methods</h4> Experimental data were extracted from...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhuo-Lei Li (Author), Qi-Bing Luo (Author), Shan-Shan Xiao (Author), Ze-Hong Lin (Author), Ye-Ling Liu (Author), Meng-Yi Han (Author), Jing-Hua Zhong (Author), Tian-Xing Ji (Author), Xu-Guang Guo (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of GeneXpert vanA/vanB in the early diagnosis of vancomycin-resistant enterococci infection.
by: Zhuo-Lei Li, et al.
Published: (2021)

Characterization of Vancomycin Resistant Enterococci and Drug Ligand Interaction between vanA of E. faecalis with the Bio-Compounds from Aegles marmelos
by: Jayavarsha V, et al.
Published: (2023)

Occult Vancomycin-Resistant <em>Enterococcus faecium</em> ST117 Displaying a Highly Mutated <em>vanB</em><sub>2</sub> Operon
by: Antonella Santona, et al.
Published: (2023)

Establishment of the GeneXpert Laboratory in Imo State, Nigeria
by: M. Mukiibi, et al.
Published: (2016)

High Incidence of Multiple-Drug-Resistant Pheromone-Responsive Plasmids and Transmissions of VanA-Type Vancomycin-Resistant <i>Enterococcus faecalis</i> between Livestock and Humans in Taiwan
by: Haruyoshi Tomita, et al.
Published: (2023)

Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis
by: Borgmann S, et al.
Published: (2019)

Utilization of GeneXpert MTB/RIF in the Southern Department of Haiti
by: T. Kedia, et al.
Published: (2015)

GeneXpert as diagnostic method of tuberculosis in Santiago de Cuba
by: Dainer Rogelio Acosta Sánchez, et al.
Published: (2022)

Fitness costs of Tn1546-type transposons harboring the vanA operon by plasmid type and structural diversity in Enterococcus faecium
by: Dokyun Kim, et al.
Published: (2024)

Validation and implementation of GeneXpert MTB/RIF for diagnosis of Tuberculosis in Ecuador
by: José Marcelo Ortíz-Jimenes, et al.
Published: (2019)

Comparison of GeneXpert MTB to Mycobacterium tuberculosis culture in children with tuberculosis
by: Betty Agustina, et al.
Published: (2019)

Effectiveness of GeneXpert® in the diagnosis of tuberculosis in people living with HIV/AIDS
by: Mariana Gaspar Botelho Funari de Faria, et al.
Published: (2021)

Use of the GeneXpert tuberculosis system for HIV viral load testing in India
by: Madlen Nash, et al.
Published: (2017)

Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho
by: Gamuchirai P. Gwaza, et al.
Published: (2023)

Evaluation of GeneXpert EV assay for the rapid diagnosis of enteroviral meningitis: a systematic review and meta-analysis
by: Min Lin, et al.
Published: (2022)

Evaluation of the GeneXpert MTB/RIF to diagnose tuberculosis in a public health laboratory
by: Mohanna Damasceno Arbués, et al.
Published: (2024)

The performance of GeneXpert® PCR assay in detecting group B streptococcus colonization at labor
by: Mohammed Rohi Khalil, et al.
Published: (2021)

Utility of GeneXpert Mycobacterium tuberculosis/rifampicin assay in smear-negative pulmonary tuberculosis
by: Javeriya Mohammadi, et al.
Published: (2021)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
by: Eric Mühlberg, et al.
Published: (2020)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
by: Talemwa Nalugwa, et al.
Published: (2020)

The impact of the coexistence of mycobacterium avium with mycobacterium tuberculosis on the result of GeneXpert and MGIT susceptibility test
by: Ali M. Bazzi, et al.
Published: (2020)

Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
by: Kristýna Hricová, et al.
Published: (2020)

GeneXpert positivity and evaluation of rifampicin resistance among endometrial biopsy specimens for the diagnosis of Genital Tuberculosis
by: Bineeta Kashyap, et al.
Published: (2020)

Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae
by: Meng-Yi Han, et al.
Published: (2021)

Validación e implementación de GeneXpert MTB/RIF para diagnóstico de tuberculosis en Ecuador
by: Ortiz-Jiménez, José Marcelo, et al.
Published: (2019)

Impact of the GeneXpert® MTB/RIF rapid molecular test on tuberculosis detection: temporal trends and vulnerable territories
by: Thaís Zamboni Berra, et al.

Vancomycin-resistant enterococci: A rising challenge to global health
by: Faiza Iqbal, et al.
Published: (2024)

Costs of two vancomycin-resistant enterococci outbreaks in an academic hospital
by: Simon van der Pol, et al.
Published: (2023)

Hospital effluent constitutes a source of vancomycin-resistant enterococci
by: Lidia Nuñez, et al.

Field evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in Tanzania.
by: Alexander Jenson, et al.
Published: (2013)

Comparative Performance of Line Probe Assay and GeneXpert in the Detection of Rifampicin Monoresistance in a TB-Endemic African Country
by: Betty R. Mchaki, et al.
Published: (2022)

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
by: Tong J, et al.
Published: (2021)

Clinical Considerations in the Approach to Vancomycin-Resistant Enterococci: A Narrative Review
by: John W. Beale, et al.
Published: (2022)

Clinical Impact of Vancomycin Treatment in Ampicillin-Susceptible Enterococci Bloodstream Infections
by: Jatapat Hemapanpairoa, et al.
Published: (2022)

Tradescantia pallida, a natural alternative against vancomycin-resistant Enterococci
by: Ranjitha Dhevi V. Sundar, et al.
Published: (2022)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
by: Mary Joyce Wingler, et al.
Published: (2021)

Die Ontwikkeling Van Genetiese Dienste Van Die Departement Van Gesondheid - 1978
by: J. Hof
Published: (1979)

Utilization of GeneXpert MTB/RIF Assay for Prevalence Mapping of Rifampicin Resistant Mycobacterium tuberculosis in A Teaching Hospital, Indonesia
by: P. Christopher, et al.
Published: (2020)

Alternatives to Fight Vancomycin-Resistant <i>Staphylococci</i> and <i>Enterococci</i>
by: Benjamin Baëtz, et al.
Published: (2021)

Vancomycin-Resistant Enterococci (VRE) in Nigeria: The First Systematic Review and Meta-Analysis
by: Yusuf Wada, et al.
Published: (2020)